Retail prices for 180 widely used specialty prescription drugs increased by an average of 4.8% in 2020, more than three times the rate of general inflation for that same period (1.3%), according to AARP’s latest Rx Price Watch Report.

AARP has launched a full-scale campaign, including a $4 million ad buy, pushing back on false claims from the pharmaceutical industry that reforms would limit Americans’ access to medicines. AARP has called for fair drug prices for years and is urging Congress to pass legislation that would allow Medicare to negotiate drug prices, put a cap on out-of-pocket costs that older adults pay for their prescription drugs and impose penalties on drug companies that raise prices faster than the rate of inflation.

AARP released the following statement from Nancy A. LeaMond, AARP Executive Vice President and Chief Advocacy & Engagement Officer in response to the Biden Administration directing all nursing homes that receive Medicare or Medicaid funds to require vaccinations for all staff

Cases of COVID-19 continue to rise among nursing home residents and staff, increasing 50% among residents and 60% among staff in July 12-18, compared to the preceding week, according to the latest data from AARP’s Nursing Home COVID-19 Dashboard.

WASHINGTON—AARP released the following statement from Nancy A. LeaMond, AARP Executive Vice President and Chief Advocacy & Engagement Officer in response to today’s Senate passage of the Infrastructure Investment and Jobs Act: